DEO vs STRO · P/E 16, $55.86B cap vs rev $62.0M
Diageo PLC ADR (DEO) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
DEO does not have a complete income-statement cache yet.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DEO currently screens at market cap $55.86B and trailing P/E 15.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DEO and STRO stock pages for the full models.
Not investment advice.